Table 3.

Two-way (2 groups × 2 concentrations) ANOVA analysis of the body mass-normalized performance in lower body Wingate test (LBWT) and upper body Wingate test (UBWT)

Variable	Effect	df	F	p	Effect size (η2)	Post-hoc outcome
LBWT mean power	Gr	1, 28	0.40	0.53	0.01
	D3 Con	1, 28	0.20	0.65	<  0.01
	D2 Con	1, 28	0.64	0.64	0.02
	Gr × D3 Con	1, 28	0.01	0.91	<  0.01
	Gr × D2 Con	1, 28	0.05	0.82	<  0.01
LBWT peak power	Gr	1, 28	0.01	0.94	<  0.01
	`D3 Con	1, 28	1.30	0.26	0.04
	D2 Con	1, 28	1.89	0.18	0.06
	Gr × D3 Con	1, 28	0.02	0.87	<  0.01
	Gr × D2 Con	1, 28	0.01	0.94	<  0.01
UBWT mean power	Gr	1, 28	13.62	0.01**	0.34	EG > PAM LD3 < HD3 LD24 < HD24
	D3 Con	1, 28	5.63	0.02*	0.18
	D2 Con	1, 28	5.70	0.02*	0.18
	Gr × D3 Con	1, 28	0.94	0.33	0.03
	Gr × D2 Con	1, 28	0.93	0.34	0.03
UBWT peak power	Gr	1, 28	6.80	0.01*	0.20	EG > PAM
	D3 Con	1, 28	2.72	0.11	0.09
	D2 Con	1, 28	2.33	0.13	0.08
	Gr × D3 Con	1, 28	0.27	0.60	0.01
	Gr × D2 Con	1, 28	0.42	0.53	0.01

Note: Gr Group, D₃ Con Concentration of 25(OH)D₃, D₂ Con Concentration of 24,25(OH)₂D₃, LD₃ Less than 22.50 ng/ml 25(OH)D₃, HD₃ More than 22.50 ng/ml 25(OH)D₃, LD₂₄ Less than 1.27 ng/ml 24,25(OH)₂D₃, HD₂₄ More than 1.27 ng/ml 24,25(OH)₂D₃, EG Elite gymnast, PAM Physically active man

Significant difference at *p ≤ 0.05, **p ≤ 0.01.